Eascra Biotech Names Andrew Goodearl Chief Scientific Officer

Company: Eascra Biotech · Event Type: CSO Appointment · Incoming: Andrew Goodearl, Ph.D. · Platform: Janus Base Nanoparticles · Date: August 27, 2026 Summary Eascra Biotech announced Andrew Goodearl, Ph.D., as chief scientific officer, adding an executive with biotherapeutics and genetic-medicine research experience to the…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Genentech / Astex | Breast Cancer Discovery Collaboration Amid gRED Restructuring
Sobi Licenses Lacutamab in $580 Million Deal
Neomorph – $100M Molecular Glue Financing
Dyne Seeks $300 Million After BLA Acceptance